Clinical Trials for High Risk Neuroblastoma

Find clinical trials for high risk neuroblastoma. Discover research opportunities and treatment options in your area.

3 Active Trials Found

Showing 3 trials on this page

Page 1 of 1

Comparing 123I-MIBG and 18F-MFBG Imaging in Patients With Newly Diagnosed, High Risk Neuroblastoma

NCT ID: NCT06858501

This clinical trial is studying a new type of imaging scan called 18F-MFBG to see if it can more accurately detect tumors in children and young adults with newly diagnosed, high-risk neuroblastoma ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

NCT ID: NCT06607692

This clinical trial, called LuPARPed, is studying a combination treatment for children and adolescents with certain types of solid tumors that have come back or have not responded to previous treat...

Recruiting

Phase: PHASE2 Type: interventional Locations: Boadilla Del Monte, Madrid, Spain

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2

NCT ID: NCT05130255

The GD2-SADA:177Lu-DOTA clinical trial is studying a new treatment for patients with certain types of solid tumors, including Small Cell Lung Cancer, Malignant Melanoma, Sarcoma, and High-Risk Neur...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chicago, Illinois, United States, Duarte, California, United States +6 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions